The advent of cancer immunotherapy has revolutionized the field of cancer treatment and
offers cancer patients new hope. Although this therapy has proved highly successful for …

This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …

The liver is endowed with an amazing regenerative capacity that allows it to withstand an
enormous amount of damage. Nevertheless, it is precisely this highly regenerative capacity …

Abstract The World Health Organization recently launched the Global Initiative for Childhood
Cancer aiming to substantially increase survival among children with cancer by 2030. The …

Background Predictions of primary liver cancer (PLC) incidence rates and case numbers are
critical to understand and plan for PLC disease burden. Methods Data on PLC incidence …

Background & Aims Taiwan has launched a series of population-wide interventions to
prevent hepatocellular carcinoma (HCC) related to hepatitis B and C virus infection since …

Simple Summary Hepatitis B virus (HBV) infection is the major risk factor for hepatocellular
carcinoma (HCC). Understanding the unique features for HBV-induced HCC can shed new …

Advancement in systemic therapy, particularly immune checkpoint inhibitor (ICI)-based
combination regimens, has transformed the treatment landscape for patients with advanced …

Simple Summary While hepatocellular carcinoma (HCC) is inextricably linked to underlying
cirrhosis due to chronic viral hepatitis, alcohol consumption, and non-alcoholic fatty liver …

Background The epidemiological association between type 2 diabetes and cataract has
been well established. However, it remains unclear whether the two diseases share a …